NDC 0135-1329

FLONASE Nighttime Allergy Relief

Triprolidine Hcl

FLONASE Nighttime Allergy Relief is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Triprolidine Hydrochloride.

Product ID0135-1329_070fb5a4-1848-41e8-90bf-57e682de1762
NDC0135-1329
Product TypeHuman Otc Drug
Proprietary NameFLONASE Nighttime Allergy Relief
Generic NameTriprolidine Hcl
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2022-12-15
Marketing CategoryOTC MONOGRAPH FINAL /
Application Numberpart341
Labeler NameGlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Substance NameTRIPROLIDINE HYDROCHLORIDE
Active Ingredient Strength3 mg/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0135-1329-01

1 BLISTER PACK in 1 CARTON (0135-1329-01) > 36 TABLET in 1 BLISTER PACK
Marketing Start Date2022-12-15
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [FLONASE]

Mark Image

Registration | Serial
Company
Trademark
Application Date
FLONASE
FLONASE
97701366 not registered Live/Pending
GlaxoSmithKline Consumer Healthcare (UK) IP Limited
2022-12-02
FLONASE
FLONASE
97121742 not registered Live/Pending
Glaxo Group Limited
2021-11-12
FLONASE
FLONASE
86746149 4959825 Live/Registered
Glaxo Group Limited
2015-09-02
FLONASE
FLONASE
85958560 4809013 Live/Registered
Glaxo Group Limited
2013-06-13
FLONASE
FLONASE
74389190 1870977 Live/Registered
GLAXO GROUP LIMITED
1993-05-11
FLONASE
FLONASE
74109574 not registered Dead/Abandoned
GLAXO GROUP LIMITED
1990-10-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.